“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare, technology, and more. Follow us on LinkedIn for upcoming editions and more information from CITI Program.
NIH's Genome Chief Says Genomics Is Evolving and Docs Need More Education on It
Source: MedPage Today National Human Genome Research Institute Director Eric Green sits down with MedPage Today.
(Login may be required)
Read The Full Article
Long COVID exercise trials proposed by NIH raise alarm
Source: Nature Advocates ask the US biomedical agency to rethink the design of its RECOVER initiative, citing possible harm and funding waste.
Read The Full Article
What are the key considerations for ethical automotive AI
Source: Automotive World Ethical questions arise when safety and UX systems become centred on understanding human behaviour, writes Rana el Kaliouby.
Read The Full Article
In a world of synthetic biology, publishing virus DNA sequences may mean perishing
Source: STAT News It is hard to imagine that a species that could figure out how to write, print and alter DNA cannot figure out a reasonable approach to regulating it.
Read The Full Article
With weight loss drug ads, telehealth companies wade into a regulatory gray area
Source: STAT News “In the old days, drug companies advertised prescription drugs, doctors prescribed prescription drugs, and pharmacies dispensed them,” said one expert.
(Login may be required)
Read The Full Article
Fast-growing open-access journals stripped of coveted impact factors
Source: Science Web of Science delists some 50 journals, including one of the world’s largest
(Login may be required)
Read The Full Article
ChatGPT Has a Big Privacy Problem
Source: Wired Italy’s recent ban of Open AI’s generative text tool may just be the beginning of ChatGPT's regulatory woes.
Read The Full Article
No kittens required: Scientists find a new way to study toxoplasmosis parasite in lab
Source: Science Reprogramming technique sheds light on mysterious life stage.
(Login may be required)
Read The Full Article
Why Diverse Clinical Trial Participation Matters
Source: New England Journal of Medicine Perspective from The New England Journal of Medicine — Why Diverse Clinical Trial Participation Matters
Read The Full Article
FDA's power tested by dueling abortion pill rulings
Source: Axios Dueling decisions on abortion pills refocus attention on legal powers FDA has over prohibited drugs — and how it can decide whether to disregard the prohibition.
Read The Full Article
